ScienceMed®

Prevalence of nasopharyngeal Streptococcus Pneumoniae carriage in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials

Infectologia
Imagem de arquivo, ilustrativa — não é do estudo. Radiografia de tórax de pulmões saudáveis. N.a. Radiology by Dr. Johan Verbeken. Scan and image editing by Vincent Mia Edie Verheyen · domínio público · Wikimedia Commons

MetanáliseNível 1 · Evidência consolidadaPloS one18 dez 20244 citações

Salvar

Resumo original em inglês

O que aconteceu

This study aims to examine the prevalence of nasopharyngeal Streptococcus pneumoniae carriage (NSPC) in infants during their first two years of life and to compare the carriage rates among different vaccine groups and country income-levels. This will be achieved through a systematic review of the published literature, specifically focusing on data from cohort studies and randomized controlled trials. A comprehensive search was conducted in four electronic databases: PubMed, Web of Science, ScienceDirect, and Scopus, using a predefined search strategy. Forty-nine articles met the inclusion criteria for this systematic review. According to the results obtained from the random effects model, the pooled mean prevalence of NSPC was 1.68% at birth (95% CI [0.50; 5.47]), 24.38% at 1 to 4 months (95% CI [19.06; 30.62]), 48.38% at 4 to 6 months (95% CI [41.68; 55.13]), 59.14% at 7 to 9 months (95% CI [50.88; 66.91]), 48.41% at 10 to 12 months (95% CI [41.54; 55.35]), 42.00% at 13 to 18 months (95% CI [37.01; 47.16]), and 48.34% at 19 to 24 months (95% CI [38.50; 58.31]). The highest NSPC rates were observed among children aged 4 to 6 months and 7 to 9 months across all vaccine groups. Low-income countries consistently demonstrated the highest NSPC rates across all age categories studied. This systematic review and meta-analysis provide robust evidence of the high prevalence of NSPC in infants aged 4 to 6 months and 7 to 9 months in all vaccine groups, with persistent regional disparities, especially among low-income countries. The study highlights the need for continuous monitoring of NSPC trends, particularly the emergence of non-vaccine serotypes. Policymakers and healthcare providers should leverage these findings to enhance vaccination strategies, aiming to minimize the overall burden of pneumococcal diseases in infants.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Prevalence of nasopharyngeal Streptococcus Pneumoniae carriage in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials

Gulzhan Beissegulova, Bakyt Ramazanova, Kamilya Mustafina, Tolkyn Begadilova, Yekaterina Koloskova, Bibigul Seitkhanova, Aliya Mamatova, Ulzhan Iskakova, Ratbek Sailaubekuly, Zhaksylyk Seiitbay

Descritores MeSH

  • Pneumococcal Vaccines
  • Nasopharynx
  • Pneumococcal Infections
  • Streptococcus pneumoniae
  • Carrier State
  • Prevalence
  • Randomized Controlled Trials as Topic
  • Humans
  • Infant
  • Infant, Newborn

Veja também